These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15179158)

  • 21. Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma.
    Drobnic F; Blanco-Alfaro J
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):223-225. PubMed ID: 29102337
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overuse of asthma medication in athletics?
    Rundell KW
    Med Sci Sports Exerc; 2004 Jun; 36(6):925. PubMed ID: 15179159
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN.
    Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ; ;
    Allergy; 2008 May; 63(5):492-505. PubMed ID: 18394123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma in United States olympic athletes who participated in the 1998 olympic winter games.
    Weiler JM; Ryan EJ
    J Allergy Clin Immunol; 2000 Aug; 106(2):267-71. PubMed ID: 10932069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma Control and Asthma Medication Use among Swedish Elite Endurance Athletes.
    Persson H; Lindberg A; Stenfors N
    Can Respir J; 2018; 2018():4646852. PubMed ID: 29743961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ample use of physician-prescribed medications in Finnish elite athletes.
    Alaranta A; Alaranta H; Heliövaara M; Airaksinen M; Helenius I
    Int J Sports Med; 2006 Nov; 27(11):919-25. PubMed ID: 16586342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of changes in anti-doping regulations (WADA Guidelines) on asthma care in athletes.
    Couto M; Horta L; Delgado L; Capão-Filipe M; Moreira A
    Clin J Sport Med; 2013 Jan; 23(1):74-6. PubMed ID: 22948449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma in elite athletes.
    Elers J; Pedersen L; Backer V
    Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical concerns with inhaled beta2-agonists: adult asthma.
    Cockcroft DW
    Clin Rev Allergy Immunol; 2006; 31(2-3):197-208. PubMed ID: 17085793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population?
    Locke S; Marks G
    Scand J Med Sci Sports; 2007 Dec; 17(6):623-7. PubMed ID: 17316378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of prescription drugs in athletes.
    Alaranta A; Alaranta H; Helenius I
    Sports Med; 2008; 38(6):449-63. PubMed ID: 18489193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of asthma in Olympic athletes--practical implications.
    Haahtela T; Malmberg P; Moreira A
    Allergy; 2008 Jun; 63(6):685-94. PubMed ID: 18445185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of asthma and permitted use of inhaled beta2-agonists in athletes.
    Bonini S; Brusasco V; Carlsen KH; Delgado L; Del Giacco SR; Haahtela T; Rasi G; van Cauwenberge PB
    Allergy; 2004 Jan; 59(1):33-6. PubMed ID: 14674930
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined Analysis of Asthma Safety Trials of Long-Acting β
    Busse WW; Bateman ED; Caplan AL; Kelly HW; O'Byrne PM; Rabe KF; Chinchilli VM
    N Engl J Med; 2018 Jun; 378(26):2497-2505. PubMed ID: 29949492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.